Reply to Thomas Seisen, Morgan Rouprêt, and Pierre Blanchard's Letter to the Editor re: Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81

Affiliations

¹ Division of Urology, Department of Surgery, Sinai Health System, Toronto, Canada; Division of Urology, Department of Surgical Oncology, University Health Network, Toronto, Canada. Electronic address: alexandre.zlotta@sinaihealth.ca.
² Department of Biostatistics, University Health Network, Toronto, Canada.
³ Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Multicenter Study

Alexandre R Zlotta et al. Eur Urol. 2024 Jan.

. 2024 Jan;85(1):e25-e26.

doi: 10.1016/j.eururo.2023.08.011. Epub 2023 Sep 1.

¹ Division of Urology, Department of Surgery, Sinai Health System, Toronto, Canada; Division of Urology, Department of Surgical Oncology, University Health Network, Toronto, Canada. Electronic address: alexandre.zlotta@sinaihealth.ca.
² Department of Biostatistics, University Health Network, Toronto, Canada.
³ Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

No abstract available

Comment on

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, Drumm M, Mari A, Thio E, Fleshner NE, Kulkarni GS, Jewett MAS, Bristow RG, Catton C, Berlin A, Sridhar SS, Schuckman A, Feldman AS, Wszolek M, Dahl DM, Lee RJ, Saylor PJ, Michaelson MD, Miyamoto DT, Zietman A, Shipley W, Chung P, Daneshmand S, Efstathiou JA. Zlotta AR, et al. Lancet Oncol. 2023 Jun;24(6):669-681. doi: 10.1016/S1470-2045(23)00170-5. Epub 2023 May 12. Lancet Oncol. 2023. PMID: 37187202